Combined FV and FVIII deficiency

Haemophilia

Volumn 14, Issue 6, 2008, Pages 1201-1208

  Spreafico, Marta ^a   Peyvandi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Combined FV + FVIII deficiency; F5F8D; LMAN1; MCFD2

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN; PROTEIN LMAN1; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 5 COMBINED HEMOPHILIA A DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BRAIN HEMORRHAGE; CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; CRYOPRECIPITATE; DRUG HALF LIFE; EPISTAXIS; ETHNICITY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GINGIVA BLEEDING; HEMARTHROSIS; HEMATOMA; HEMOPHILIA A; HUMAN; INCIDENCE; MENORRHAGIA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEONATAL HEMORRHAGE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RACE DIFFERENCE;

BLOOD COAGULATION; COAGULANTS; DEAMINO ARGININE VASOPRESSIN; DNA MUTATIONAL ANALYSIS; FACTOR V DEFICIENCY; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; MUTATION; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RARE DISEASES; VESICULAR TRANSPORT PROTEINS;

EID: 55949096229     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01845.x     Document Type: Article

References (43)

1. Giddings JC, Seligsohn U, Bloom AL. Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol 1977; 37: 257-64.
2. Oeri J, Matter M, Isenschmid H, Hauser F, Koller F. Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers. Bibl Paediatr 1954; 58: 575-88.
3. Saito H, Shioya M, Koie K, Kamiya T, Katsumi O. Congenital combined deficiency of factor V and factor 8. A case report and the effect of transfusion of normal plasma and hemophilic blood. Thromb Diath Haemorrh 1969; 22: 316-25.
4. Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-85.
5. Gitschier J, Wood WI, Goralka TM et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-30.
6. Nichols WC, Seligsohn U, Zivelin A et al. Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest 1997; 99: 596-601.
7. Nichols WC, Seligsohn U, Zivelin A et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998; 93: 61-70.
8. Zhang B, Cunningham MA, Nichols WC et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet 2003; 34: 220-5.
9. Zhang B, Kaufman RJ, Ginsburg D. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem 2005; 280: 25881-6.
10. Zhang B, McGee B, Yamaoka JS et al. Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood 2006; 107: 1903-7.
11. Mannucci PM, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
12. Seligsohn U, Zivelin A, Zwang E. Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med 1982; 307: 1191-5.
13. Segal A, Zivelin A, Rosenberg N, Ginsburg D, Shpilberg O, Seligsohn U. A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia. Blood Coagul Fibrinolysis 2004; 15: 99-102.
14. Mansouritorgabeh H, Rezaieyazdi Z, Pourfathollah AA, Rezai J, Esamaili H. Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran. Haemophilia 2004; 10: 271-5.
15. Peyvandi F, Tuddenham EG, Akhtari AM, Lak M, Mannucci PM. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol 1998; 100: 773-6.
16. Neerman-Arbez M, Antonarakis SE, Blouin JL et al. The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. Am J Hum Genet 1997; 61: 143-50.
17. Neerman-Arbez M, Johnson KM, Morris MA et al. Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency. Blood 1999; 93: 2253-60.
18. Zhang B, Spreafico M, Zheng C et al. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. Blood 2008; 111: 5592-600.
19. Nichols WC, Terry VH, Wheatley MA et al. ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood 1999; 93: 2261-6.
20. D'Ambrosio R, Santacroce R, Di Perna P, Sarno M, Romondia A, Margaglione M. A new case of combined factor V and factor VIII deficiency further suggests that the LMAN1 M1T mutation is a frequent cause in Italian patients. Blood Coagul Fibrinolysis 2007; 18: 203-4.
21. Faioni EM, Fontana G, Carpani G et al. Review of clinical, biochemical and genetic aspects of combined factor V and factor VIII deficiency, and report of a new affected family. Thromb Res 2003; 112: 269-71.
22. Farah RA, de Moerloose P, Bouchardy I et al. Combined factor V - factor VIII deficiency (F5F8D): Compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient. Thromb Haemost 2006; 95: 893-5.
23. Shukla J, Singhal R, Garbyal RS, Singh VP, Dube B. Hereditary combined coagulation factor V and factor VIII deficiency: Report of two Indian families from Varanasi. Indian J Pathol Microbiol 2002; 45: 151-4.
24. Shetty S, Madkaikar M, Nair S et al. Combined factor V and VIII deficiency in Indian population. Haemophilia 2000; 6: 504-7.
25. Mohanty D, Ghosh K, Shetty S, Spreafico M, Garagiola I, Peyvandi F. Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII. Am J Hematol 2005; 79: 262-6.
26. Jayandharan G, Spreafico M, Viswabandya A, Chandy M, Srivastava A, Peyvandi F. Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India. Haemophilia 2007; 13: 413-9.
27. Dansako H, Ishimaru F, Takai Y et al. Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V-factor VIII deficiency. Ann Hematol 2001; 80: 292-4.
28. Ma ES, Wong CL, Lam HY, Wang CL, Ma SY. Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene. Br J Haematol 2007; 139: 509-11.
29. Sirachainan N, Zhang B, Chuansumrit A, Pipe S, Sasanakul W, Ginsburg D. Combined factor V and factor VIII deficiency in a Thai patient: A case report of genotype and phenotype characteristics. Haemophilia 2005; 11: 280-4.
30. Nyfeler B, Kamiya Y, Boehlen F et al. Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. Blood 2008; 111: 1299-301.
31. Cunningham MA, Pipe SW, Zhang B, Hauri HP, Ginsburg D, Kaufman RJ. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J Thromb Haemost 2003; 1: 2360-7.
32. Itin C, Roche AC, Monsigny M, Hauri HP. ERGIC-53 is a functional mannose-selective and calcium-dependent human homologue of leguminous lectins. J Cell Biol 1996; 107: 483-93.
33. Velloso LM, Svensson K, Schneider G, Pettersson RF, Lindqvist Y. Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a protein involved in glycoprotein export from the endoplasmic reticulum. J Biol Chem 2002; 277: 15979-84.
34. Velloso LM, Svensson K, Pettersson RF, Lindqvist Y. The crystal structure of the carbohydrate-recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J Mol Biol 2003; 334: 845-51.
35. Wen C, Greenwald I. p24 proteins and quality control of LIN-12 and GLP-1 trafficking in Caenorhabditis elegans. J Cell Biol 1999; 145: 1165-75.
36. Kawasaki N, Ichikawa Y, Matsuo I et al. The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood 2008; 111: 1972-9.
37. Nyfeler B, Zhang B, Ginsburg D, Kaufman RJ, Hauri HP. Cargo selectivity of the ERGIC-53/MCFD2 transport receptor complex. Traffic 2006; 7: 1473-81.
38. Vollenweider F, Kappeler F, Itin C, Hauri HP. Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol 1998; 142: 377-89.
39. Bolton-Maggs PH, Perry DJ, Chalmers EA et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 593-628.
40. Peyvandi F, Mannucci PM. Rare Coagulation Disorders. Thromb Haemost 1999; 82: 1207-14.
41. Di Paola J, Nugent D, Young G. Current therapy for rare factor deficiency. Haemophilia 2001; 7 (suppl. 1): 16-22.
42. Goudemand J, Rothschild C, Demiguel V et al. Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A. Blood 2006; 107: 46-51.
43. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-21.